TULSA, Okla., July 26, 2005 (PRIMEZONE) -- Maxxon, Inc. (Pink Sheets:MXON) ("Maxxon") today announced that it has added a second product to its recently created Joint Venture with Globe Med Tech ("Globe") of Houston, Texas.
Maxxon has exercised its option for its recently formed Joint Venture, a 50/50 owned venture between Maxxon and Globe, to acquire the patented "Auto Retractable Safety Scalpel with Permanent Lock," including patent rights. The Safety Scalpel is the only spring-loaded automatic retractable Scalpel that permanently locks using a one-handed technique and is currently being manufactured. Globe is beginning a marketing campaign to distribute the product.
"The Joint venture with Globe Med Tech is clearly a win-win situation. It brings together two companies with diverse backgrounds with distinct strengths, allowing both parties to focus on their forte. Globe will continue to evaluate new safety products and patents and will attempt to bring related products and technologies to the Joint Venture," stated Ron Wheet, CEO of Maxxon.
About Maxxon
Maxxon is a development stage company committed to reducing the risk of accidental needlestick injuries and deaths to healthcare workers. Maxxon's 3cc. safety syringe, presently in development, is designed as a single-handed, vacuum-operated safety syringe that retracts the used needle into the syringe after use.
For more information on Maxxon please go to www.maxxoninc.com or call Brian Heckathorne at 713-297-8886.
About Globe Med Tech
Globe Med Tech, Inc. is a high-tech medical safety and drug delivery products developer and manufacturer based in Houston, Texas; with a clean-room manufacturing presence in China. Globe Med Tech has marketed its products in the U.S. and around the world, providing the medical industry with innovative low-cost, high-quality medical products. Globe Med Tech's team has accumulated valuable integration experience for medical devices, while establishing itself as a cost effective operator in the medical device industry. Whether under the Company's brand name, or under a private label, Globe Med Tech has a history of effectively integrating patent development, research, and engineering design capabilities.
For more information on Globe please go to www.globemedtech.com . This press release contains some forward-looking statements. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Forward-looking statements in this document should be evaluated together with the many uncertainties that affect our business. Those uncertainties are discussed in Maxxon's SEC filings.